Cellosaurus HRL9 (CVCL_GZ13)
| Cell line name | HRL9 |
|---|---|
| Synonyms | HRL9 HeLa |
| Accession | CVCL_GZ13 |
| Resource Identification Initiative | To cite this cell line use: HRL9 (RRID:CVCL_GZ13) |
| Comments | Population: African American. Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16. Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR. Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del). Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Firefly luciferase. Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18). Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. |
| Disease | Human papillomavirus-related cervical adenocarcinoma (NCIt: C27677) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_2505 (HR5) |
| Sex of cell | Female |
| Age at sampling | 30Y6M |
| Category | Cancer cell line |
| Publications | PubMed=10738580; DOI=10.1002/(SICI)1521-2254(199901/02)1:1<4::AID-JGM4>3.0.CO;2-Y |
| Cross-references | |
| Cell line databases/resources | TOKU-E; 4131 |
| Encyclopedic resources | Wikidata; Q54895232 |
| Entry history | |
| Entry creation | 26-Sep-2016 |
| Last entry update | 10-Sep-2024 |
| Version number | 13 |